Characteristics in relation to demographic, disease related and clinical variables of a cohort of Parkinson’s disease patients from Northern Sri Lanka
Objective: To evaluate motor and non-motor domains, as well as for demographic and disease related characteristics of patients with Parkinson’s disease and the relations with…Non-motor outcomes of subthalamic DBS in PD depend on the location of volume of activated tissue
Objective: To investigate the impact of stimulation location on non-motor symptoms (NMS) in PD patients with DBS in the subthalamic nucleus (STN) via an analysis…Stigma and communication in people with Parkinson’s disease (PPD)
Objective: To present results about stigma in PPD from a Parkinson’s Workshop. These are preliminary results in the path to address the main project question…Prevalence and Correlates of Anxiety & Depression in Cervical Dystonia
Objective: Our aim was to assess the prevalence and severity of mood disorder in our Cervical Dystonia population attending the botulinum toxin clinic and to…Higher Levels of Serum Uric Acid Associated with Motor & Non-Motor Symptoms in Early Parkinson’s Disease
Objective: Uric acid (UA) has been shown to be potentially neuroprotective in Parkinson's disease (PD), a progressive neurodegenerative disorder that is clinically characterised by motor…Utilizing latent class analysis to explore the sleep disturbance subtypes in Parkinson’s disease patients
Objective: The aim of this study was to analyze whether distinct sleep disturbance subtypes could be empirically identified in patients with Parkinson’s disease (PD) based…Sleep, Fatigue and Health-related quality of life in a cohort of Parkinson disease patients
Objective: To determine frequencies of non-motor symptoms (NMS) specifically sleep disorders, fatigue and mood disorders in a cohort of Nigerians with PD seen at the…Exploration of insight competence in Huntington’s disease supplemental to a cognitive debriefing study for the FuRST2.0 rating scale
Objective: Evaluate insight of functional impairment in premanifest and early-manifest Huntington’s disease (HD). Background: Following the guidelines of the US Food and Drug Administration Clinical…Substantia Nigra Echogenicity Associated with Clinical Subtypes of Parkinson’s Disease
Objective: We classified Parkinson’s disease (PD) patients into different subtypes and evaluated the correlation between the substantia nigra (SN) echogenicity and disease progression. Background: It…Assessment of pain and its correlation with quality of life in Parkinson’s disease
Objective: The study was carried out to assess the prevalence of pain, nature of pain, quality of life and correlation of pain with quality of…
- « Previous Page
- 1
- …
- 37
- 38
- 39
- 40
- 41
- …
- 51
- Next Page »